Thermo Fisher Scientific (TMO) Other Non Operating Income (2009 - 2026)

Thermo Fisher Scientific has disclosed Other Non Operating Income across 18 years of filings, most recently posting -$9.0 million for Q1 2026.

• Quarterly Other Non Operating Income fell 400.0% year-over-year to -$9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.0 million (down 500.0% YoY) and the FY2025 annual result came in at -$12.0 million, down 200.0% from the prior year.
• Other Non Operating Income eased to -$9.0 million in Q1 2026, from $6.0 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $35.0 million in Q4 2022 and troughed at -$163.0 million in Q2 2022.
• A 5-year average of -$11.1 million and a median of $500000.0 in 2025 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2022 — Other Non Operating Income surged 1033.33% — and 2025, when it plunged 480.0%.
• Tracing TMO's Other Non Operating Income over 5 years: stood at $35.0 million in 2022, then tumbled by 194.29% to -$33.0 million in 2023, then soared by 142.42% to $14.0 million in 2024, then tumbled by 57.14% to $6.0 million in 2025, then sank by 250.0% to -$9.0 million in 2026.
• Business Quant data shows TMO's Other Non Operating Income at -$9.0 million in Q1 2026, $6.0 million in Q4 2025, and -$2.0 million in Q3 2025.